Global Lung Cancer Surgery Market Size Study & Forecast, by Instrument (Clamps, Forceps, Trocars, Retractors, Scissors, Monitoring & Endoscopic Devices), Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy, Sleeve Resection), MIS) and Regional

The Global Lung Cancer Surgery Market is valued at approximately USD 6.27 billion in 2024 and is anticipated to grow with a steady CAGR of more than 3.80% over the forecast period 2025-2035. Lung cancer surgery, which is a cornerstone in the treatment of lung malignancies, encompasses a wide range of advanced surgical procedures and devices that allow surgeons to effectively remove cancerous tissue, preserve lung function, and improve patient outcomes. With the rising global burden of lung cancer driven by tobacco consumption, air pollution, occupational hazards, and genetic predispositions, the demand for surgical interventions has continued to surge. Increasing adoption of minimally invasive surgical (MIS) techniques and the integration of advanced monitoring and endoscopic devices have further reshaped the surgical landscape, enabling healthcare providers to deliver safer, faster, and more efficient procedures.

The accelerating prevalence of lung cancer has significantly heightened the necessity for surgical procedures, thereby augmenting the demand for specialized instruments and advanced technologies. According to the World Health Organization, lung cancer remains the leading cause of cancer-related deaths globally, accounting for nearly 1.8 million deaths annually. Technological advancements such as robotic-assisted thoracic surgery, video-assisted thoracoscopic surgery (VATS), and precision-driven surgical tools are creating opportunities for enhanced procedural outcomes and reduced post-operative complications. Moreover, the growing emphasis on early detection programs and government initiatives to improve cancer treatment infrastructure are expected to fuel market expansion. However, high surgical costs, limited access to advanced healthcare facilities in developing regions, and the rising adoption of alternative therapies may hinder the market trajectory during the forecast period.

Regionally, North America accounted for the largest share of the global Lung Cancer Surgery Market in 2025, owing to its highly developed healthcare infrastructure, strong presence of key medical device manufacturers, high prevalence of lung cancer cases, and rapid adoption of cutting-edge surgical technologies. Europe also represents a significant market, driven by favorable reimbursement policies, advanced cancer screening programs, and increased awareness regarding surgical treatment options. Meanwhile, Asia Pacific is poised to witness the fastest growth over the forecast horizon, fueled by surging incidences of lung cancer due to rising smoking rates, rapid urbanization, and growing air pollution levels in densely populated countries such as China and India. Expanding healthcare investments, growing demand for minimally invasive procedures, and the availability of skilled thoracic surgeons further amplify the region’s growth potential. Latin America and the Middle East & Africa are also expected to experience steady growth, supported by improvements in healthcare access and rising government spending on cancer treatment initiatives.

Major market player included in this report are:
• Medtronic plc
• Johnson & Johnson (Ethicon, Inc.)
• Olympus Corporation
• Siemens Healthineers AG
• Intuitive Surgical, Inc.
• Boston Scientific Corporation
• Zimmer Biomet Holdings, Inc.
• Stryker Corporation
• Smith & Nephew plc
• B. Braun Melsungen AG
• KARL STORZ SE & Co. KG
• Fujifilm Holdings Corporation
• Accuray Incorporated
• CONMED Corporation
• Terumo Corporation

Global Lung Cancer Surgery Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Instrument:
• Clamps
• Forceps
• Trocars
• Retractors
• Scissors
• Monitoring & Endoscopic Devices

By Procedure:
• Thoracotomy
• Lobectomy
• Pneumonectomy
• Segmentectomy
• Sleeve Resection
• Minimally Invasive Surgery (MIS)

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more